- E-mailjubayer.hossain@uib.no
- Visitor AddressJonas Lies vei 915009 Bergen
- Postal AddressPostboks 78045020 Bergen
Teaching:
- Tumor Biology; BMED 331 (https://www.uib.no/emne/BMED331). Topics: Tumor Ecosystem, Treatments and resistance
- Methods in Biomedical Research; BMED320 (Methods in Biomedical Research | Universitetet i Bergen (uib.no)
Supervision:
- PhD-candidates: 3
- MSc students: 8
- Medicine students: 1
- BSc students: 2
2023
1. Deciphering human glioblastoma invasion using a fully differentiated rat brain organoid model. Zhou W, ……Hossain JA, …Bjerkvig R. (Submitted). 2023. IF: Ikke aktuelt
2. Sajib SS, Hossain JA and Das MK. Stem Cell-Based Regenerative Medicine Therapy in Cancer. In: Haider, K.H. (eds) Handbook of Stem Cell Applications. Springer, Aug, 2023 IF: Ikke aktuelt
3. Watson D, …… Hossain JA…Lathia J. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nature Cancer, May, 2023, IF: 23.1
2022
4. Ferreira T, ….. Hossain JA, ……and Marchini A. Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells. Viruses . 2022 May 11;14(5):1018, IF 5.8
5. Andersen JK, Miletic H, Hossain JA*. Tumor-associated macrophages in gliomas – basic insights and treatment opportunities. Cancers (Basel) . 2022 Mar 4;14(5):1319., IF 6.6
2021
6. Joseph JJ, Magaut CR, ….. Hossain JA, …., Daubon T, Miletic H. TGF-β promotes microtube formation in glioblastoma through Thrombospondin. Neuro Oncol . 2022 Apr 1;24(4):541-55. IF: 15.9
7. Zhao D, Zhang H, ….. Hossain JA, … Glass R 1and Kälin R. Comparing Tumor Cell Invasion and Myeloid Cell Composition in Compatible Primary and Relapsing Glioblastoma. Cancers 2021, 13. 2021. IF: 6.6
8. Kulkarni A, Ferreira T, ……., Hossain JA, ……Brino L and Marchini A. Oncolytic H1-parvovirus hijacks laminins for cell attachment and entry. Nat Commun. 2021 Jun 22;12(1). IF: 14.9
9. The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment. Das MK, Miletic H, and Hossain JA*. Advances in Experimental Medicine and Biology. 2021. IF: 2.4.
2020
10. Hossain JA, Miletic H. Letter regarding “Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas”. Neuro-Oncology. 2020. IF: 15.9
11. Hossain JA*, Marchini A, Fehse B, Bjerkvig R and Miletic H. Suicide Gene Therapy for the treatment of High-grade Gliomas: Past Lessons, Present Trend and Future Remarks. NeuroOncology Advances, 2 (1) 2020.. IF: N/A 2019
12. Hossain JA, Ystaas LAR, Latif MA, Ninzima S, Joseph JV, Talasila KM, Ghimire J, Riecken K, Fehse B, Bjerkvig R and Miletic H. Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma, Neuro-Oncology, 21(7). 2019. IF: 15.9
13. Hossain JA, Riecken K, Miletic H, Fehse B. Cancer Suicide Gene Therapy with TK.007. Methods Mol Biol. 2019; 1895:11-26. IF: 1.29. før 2019
14. Talasila KM, Røsland GV, Hagland HR, …. Joseph JV, Hossain JA, Vallar L, ……. Bjerkvig R and Miletic H. The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro Oncol. 2017 Mar 1;19(3):383-393. IF: 15.9
15. Eskilsson E, Rosland GV, ……Välk K, Al Hossain J, ....Bjerkvig R, and Miletic H. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro Oncol. 2016 Dec;18(12):1644-1655. Epub 2016 Jun 10. IF: 15.9
16. Hossain JA, Ystaas LR, Mrdalj J, Välk K, Riecken K, Fehse B, Bjerkvig R, Grønli J,Miletic H. Lentiviral HSV-Tk.007 mediated suicide gene therapy is not toxic for normal brain cells. J Gene Med. 18(9).2016. IF: 4.5 17. Samoylenko A*, Hossain JA*, Mennerich D, Kellokumpu S, Hiltunen JK, Kietzmann T. Nutritional Countermeasures Targeting Reactive Oxygen Species in Cancer: From Mechanisms to Biomarkers and Clinical Evidence. Antioxid Redox Signal. 2013 Dec 10; 19(17): 2157–2196. *Co-first author. IF: 8.4
- (2023). Stem Cell-Based Regenerative Medicine Therapy in Cancer. Springer Nature.
- (2023). GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nature Cancer. 648-664.
- (2022). Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells. Viruses. 25 pages.
- (2021). TGF-β promotes microtube formation in glioblastoma through thrombospondin 1. Neuro-Oncology. 541-553.
- (2021). Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry. Nature Communications.
- (2021). Comparing tumor cell invasion and myeloid cell composition in compatible primary and relapsing glioblastoma. Cancers. 1-17.
- (2020). Letter regarding "Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas". Neuro-Oncology. 1882-1883.
- (2019). Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. Neuro-Oncology. 890-900.
- (2017). The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro-Oncology. 383-393.
- (2016). Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells. Journal of Gene Medicine. 234-243.
- (2016). EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro-Oncology. 1644-1655.
- (2023). Investigation of the apoptotic pathway in glioblastoma in the context of suicide gene therapy.
- (2020). Studies on the Molecular Mechanisms of the Bystander Effect in HSV-TK mediated Suicide Gene Therapy for Glioblastoma Treatment.
- (2019). Use of Gap Junction Enhanching Drugs to Increase the Bystander Effect of Sucide Gene Therapy for Glioblastoma Treatment.
- (2017). Screening of tumor suppressor microRNAs to boost the killing efficacy of suicide gene therapy for brain cancer treatment.
- (2019). Cancer Suicide Gene Therapy with TK.007. 16 pages.
- (2022). Tumor-associated macrophages in gliomas—basic insights and treatment opportunities. Cancers. 1-25.
- (2020). Suicide gene therapy for the treatment of high-grade glioma: Past lessons, present trends, and future prospects. Neuro-Oncology Advances (NOA).
- (2019). The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment. . In:
- (2019). Advances in Experimental Medicine and Biology. Springer Nature.
More information in national current research information system (CRIStin)
- Immunotherapy of solid cancers
- Suicide Gene Therapy for the Treatment of Brain tumors
- Oncolytic Virotherapy by H1 PV Virus for the Treatment of Various Cancers
- Molecular Mechanism of Bystander effect in HSV-TK/GCV Gene therapy